VATE
Get informed when a big investor buys or sells
+ FollowOvervalued by 231.6% based on the discounted cash flow analysis.
| Market cap | $110.77 Million |
|---|---|
| Enterprise Value | $586.97 Million |
| Dividend Yield | $0.78 (9.61%) |
| Earnings per Share | $-4.84 |
| Beta | 2.3 |
| Outstanding Shares | 13,344,976 |
| P/E Ratio | -1.91 |
|---|---|
| PEG | 6.41 |
| Price to Sales | 0.07 |
| Price to Book Ratio | -0.41 |
| Enterprise Value to Revenue | 0.44 |
| Enterprise Value to EBIT | -9.26 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 1.04 |
| Debt to Equity | 56.56 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 17.99%▼ 0.65% |
|---|---|
| Total Invested | $13.63M▲ 21.30% |
| Investors Holding | 31▲ 3.00% |
No data
HC2 Holdings, Inc.has a class-leading portfolio of assets primarily in Infrastructure, Life Sciences, Spectrum and Insurance. HC2 is headquartered in New York, New York and through its subsidiaries employs more than 2,800 people.